Cyclenium Pharma Inc.

The anti-infectives developer AiCuris Anti-infective Cures GmbH has signed a long-term co-operation agreement to develop and optimize a novel class of antibacterials from Liechtenstein-based Lysando

Cyclenium Pharma Inc. , founded five years ago by Helmut Thomas and Mark Petersen in Quebec, Canada, is a small molecule macrocycle company with a drug discovery technology, Customized Macrocycles for

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

IN VITRO DIAGNOSTICS Alliances Biohit Oyj Mekalasi Oy Mekalasi Oy agreed to distribute four of Biohit Oyj ’s Quick Tests in Finland. (May) Included in the deal are the Heliobacter Pylori UFT300